About this episode

The episode discusses how regulations in the EU and US shape the development and approval of medical devices.

Medical devices range from simple fillings to highly sophisticated robotics, with more than half a million available in the EU alone. However, regulations differ widely across regions and countries. What does this mean for medical device development around the world? In this episode of Balancing the Future , Micah and Chai interview Dr. Dominik Lysek, Executive Board Member and CEO of PharmaTrail, a software company that helps pharmaceutical, biotech, and medtech companies manage clinical trial data with blockchain technology. Dominik has worked with medical devices throughout his career and has closely followed both the EU and US markets. Dominik explains how the EU and the US each regulate their medical device markets. One key difference is that the US provides clear timelines for approvals, while Europe does not set specific deadlines. In the EU, even a modified version of an already approved and safe product still needs to go through regulatory approval. However, new Medical Device Regulation 2.0 legislation now being considered by the EU parliament could change this by introducing clear deadlines and reducing bureaucracy. Even with these possible changes, both the EU and US…

Topics covered

• medical devices
• regulations
• clinical trials
• EU market
• US market
• blockchain technology

More episodes of Balancing The Future

• The Bioreactor Breakthrough: Crafting Coffee and Cocoa in the Lab · June 29, 2026 · 21 min
• Democratizing Global Science: The Power of Redistributing Lab Equipment · June 15, 2026 · 21 min

Explore listener stats, chart rankings, contacts and more on the Balancing The Future podcast page.